|1.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/01/1988 - "Modulation of sensitivity to mitoxantrone in human chronic myeloid leukemia cells by the antidepressant sintamil."
10/31/1986 - "The in vitro effect of sintamil, as a modulator alone and in combination with hydroxyurea (HU), on cytotoxicity was studied in 16 cases of human chronic myeloid leukemia (CML). "
10/31/1986 - "Augmentation of hydroxyurea cytotoxicity by sintamil in human chronic myeloid leukemia cells."
01/01/1987 - "Attempts were made to reverse the acquired resistance of P388 murine leukemia utilizing non-toxic concentration of nitroxazepine hydrochloride, an antidepressant. "
01/01/1987 - "The survival of mice bearing adriamycin-resistant P388 murine leukemia cells treated in vitro with nitroxazepine hydrochloride, adriamycin and a combination of the two drugs was also investigated. "
01/01/1987 - "Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycin."
01/01/1987 - "The results show that treatment of these cells with nitroxazepine hydrochloride significantly enhanced (1) the intracellular accumulation of adriamycin, (2) inhibition of DNA biosynthesis, and (3) the survival of mice transplanted with adriamycin-resistant P388 murine leukemia cells treated in vitro with a combination of nitroxazepine hydrochloride and adriamycin. "
04/01/1986 - "Hepatitis following nitroxazepine therapy."
|4.||DNA (Deoxyribonucleic Acid)